Arkolith/Insider Trading/VRDN/Form 4

Katz Barrett

Chief Medical OfficerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jan 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 17, 2023Option exercise(M)25K$23.03$572K25K
Jan 17, 2023Sell(S)25K$37.21$925K0
Jan 13, 2023Option exercise(M)4K$23.03$96K4K
Jan 13, 2023Sell(S)4K$37.01$153K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 17, 2023Option exercise(M)25K—$0267K
Jan 13, 2023Option exercise(M)4K—$0292K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-002075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML